The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis /631/154/51/1568 /631/250/98 /13/21 /13/1 /13/31 /38/77 /64/60 /82/51 /13 article

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Pei, Xiaolei ^a,c   Zheng, Danfeng ^a   She, Shaoping ^a   Ma, Jing ^a   Guo, Changyuan ^d   Mo, Xiaoning ^b   Zhang, Yingmei ^a,b   Song, Quansheng ^a,b   Zhang, Yu ^a   Ma, Dalong ^a,b   Wang, Ying ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^d CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA-MICROSEMINOPROTEIN; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; DEXTRAN SULFATE; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTATIC SECRETORY PROTEIN; TUMOR NECROSIS FACTOR; TUMOR PROTEIN;

ANIMAL; CELL MOTION; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; HUMAN; MACROPHAGE; MALE; METABOLISM; MONOCYTE; MOUSE; UPREGULATION;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL2; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MONOCYTES; NEOPLASM PROTEINS; PROSTATIC SECRETORY PROTEINS; RECEPTORS, CCR2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 85023185749     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-05255-7     Document Type: Article

References (56)

1. Kassam, Z. et al. Inflammatory bowel disease cause-specific mortality: A primer for clinicians. Inflamm Bowel Dis 20, 2483-92 (2014).
2. Yashiro, M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol 20, 16389-97 (2014).
3. Lakatos, L. et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 12, 205-11 (2006).
4. Pohl, C., Hombach, A. & Kruis, W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 47, 57-70 (2000).
5. Bain, C. C. & Mowat, A. M. Intestinal macrophages-specialised adaptation to a unique environment. Eur J Immunol 41, 2494-8 (2011).
6. Racine, R., Chatterjee, M. & Winslow, G. M. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection. J Immunol 181, 1375-85 (2008).
7. Liu, K. et al. In vivo analysis of dendritic cell development and homeostasis. Science 324, 392-7 (2009).
8. Smith, P. D. et al. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol 4, 31-42 (2011).
9. Zigmond, E. et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigenpresenting cells. Immunity 37, 1076-90 (2012).
10. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
11. Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I. & Stappenbeck, T. S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 102, 99-104 (2005).
12. Gordon, S. & Taylor, P. R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5, 953-64 (2005).
13. Sunderkotter, C. et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 172, 4410-7 (2004).
14. Crane, M. J., Hokeness-Antonelli, K. L. & Salazar-Mather, T. P. Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J Immunol 183, 2810-7 (2009).
15. Serbina, N. V. & Pamer, E. G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7, 311-7 (2006).
16. Shi, C. et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 34, 590-601 (2011).
17. Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 29, 313-26 (2009).
18. Takada, Y. et al. Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset. J Immunol 184, 2671-6 (2010).
19. Yadav, A., Saini, V. & Arora, S. MCP-1: chemoattractant with a role beyond immunity: A review. Clin Chim Acta 411, 1570-9 (2010).
20. Andres, P. G. et al. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfatemediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J Immunol 164, 6303-12 (2000).
21. Waddell, A. et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11. J Immunol 186, 5993-6003 (2011).
22. Valtonen-Andre, C. et al. A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue. Biol Chem 388, 289-95 (2007).
23. Pei, X. et al. PC3-secreted microprotein is a novel chemoattractant protein and functions as a high-affinity ligand for CC chemokine receptor 2. J Immunol 192, 1878-86 (2014).
24. Low, D., Mino-Kenudson, M. & Mizoguchi, E. Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis 20, 2115-23 (2014).
25. Minami, N., Yoshino, T. & Nakase, H. Unique endoscopic findings of colitis-associated colorectal cancer in a patient with ulcerative colitis and Lynch syndrome. J Crohns Colitis 8, 336-7 (2014).
26. Alexander, K. L., Targan, S. R. & Elson, C. R. Microbiota activation and regulation of innate and adaptive immunity. Immunol Rev 260, 206-20 (2014).
27. O'Toole, A. & Korzenik, J. Environmental triggers for IBD. Curr Gastroenterol Rep 16, 396 (2014).
28. Kawada, M., Arihiro, A. & Mizoguchi, E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 13, 5581-93 (2007).
29. Perse, M. & Cerar, A. Dextran sodium sulphate colitis mouse model: Traps and tricks. J Biomed Biotechnol 2012, 718617 (2012).
30. Corridoni, D., Arseneau, K. O. & Cominelli, F. Inflammatory bowel disease. Immunol Lett 161, 231-5 (2014).
31. Neurath, M. F. Cytokines in inflammatory bowel disease. Nat Rev Immunol 14, 329-42 (2014).
32. Gersemann, M., Wehkamp, J. & Stange, E. F. Innate immune dysfunction in inflammatory bowel disease. J Intern Med 271, 421-8 (2012).
33. Gersemann, M., Wehkamp, J., Fellermann, K. & Stange, E. F. Crohn's disease-defect in innate defence. World J Gastroenterol 14, 5499-503 (2008).
34. Wehkamp, J. & Stange, E. F. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 1072, 321-31 (2006).
35. Asano, K. et al. Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes. Nat Commun 6, 7802 (2015).
36. Weisberg, S. P. et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116, 115-24 (2006).
37. Pott, J. & Hornef, M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep 13, 684-98 (2012).
38. Reynolds, J. M. et al. Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation. Immunity 42, 692-703 (2015).
39. Geremia, A., Biancheri, P., Allan, P., Corazza, G. R. & Di Sabatino, A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 13, 3-10 (2014).
40. Siegmund, B. & Zeitz, M. Innate and adaptive immunity in inflammatory bowel disease. World J Gastroenterol 17, 3178-83 (2011).
41. Ullman, T. A. & Itzkowitz, S. H. Intestinal inflammation and cancer. Gastroenterology 140, 1807-16 (2011).
42. Wang, D., Dubois, R. N. & Richmond, A. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol 9, 688-96 (2009).
43. Jung, S. Dendritic cells: A question of upbringing. Immunity 32, 502-4 (2010).
44. Geuking, M. B. et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34, 794-806 (2011).
45. Song, M. Y. et al. Protective effects of Fc-fused PD-L1 on two different animal models of colitis. Gut 64, 260-71 (2015).
46. Nau, D., Altmayer, N. & Mattner, J. Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation. J Immunol Res 2014, 546596 (2014).
47. Varol, C. et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31, 502-12 (2009).
48. Bogunovic, M. et al. Origin of the lamina propria dendritic cell network. Immunity 31, 513-25 (2009).
49. Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 14, 392-404 (2014).
50. Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656-61 (2010).
51. Dutta, P. & Nahrendorf, M. Regulation and consequences of monocytosis. Immunol Rev 262, 167-78 (2014).
52. Gunaltay, S. et al. Enhanced levels of chemokines and their receptors in the colon of microscopic colitis patients indicate mixed immune cell recruitment. Mediators Inflamm 2015, 132458 (2015).
53. Liang, X., Li, H., Tian, G. & Li, S. Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer. Sci Rep 4, 4985 (2014).
54. Drakes, M. L., Czinn, S. J. & Blanchard, T. G. Isolation and purification of colon lamina propria dendritic cells from mice with colitis. Cytotechnology 46, 151-61 (2004).
55. Xing, S. et al. Targeting endothelial CD146 attenuates colitis and prevents colitis-associated carcinogenesis. Am J Pathol 184, 1604-16 (2014).
56. Liu, Y. et al. Mouse macrophage polarity and ROCK1 activity depend on RhoA and non-apoptotic Caspase 3. Exp Cell Res 341, 225-36 (2016).